Company Puma Biotechnology Inc Nyse
Equities
US74587V1070
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cancer Care Products
100.0
%
| 228 | 100.0 % | 236 | 100.0 % | +3.34% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 228 | 100.0 % | 236 | 100.0 % | +3.34% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 14/09/10 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 04/11/18 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 28/02/13 |
Investor Relations Contact | - | - | |
Jeffrey Ludwig
PRN | Corporate Officer/Principal | 58 | 29/02/20 |
Douglas Hunt
LAW | General Counsel | 59 | 31/12/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 22/02/18 |
Jay Moyes
BRD | Director/Board Member | 70 | 26/04/12 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 14/09/10 |
Director/Board Member | 63 | 28/07/22 | |
Director/Board Member | 60 | 10/08/15 | |
Troy Wilson
BRD | Director/Board Member | 55 | 17/10/13 |
Allison Dorval
BRD | Director/Board Member | 48 | 14/07/21 |
Brian Stuglik
BRD | Director/Board Member | 64 | 04/07/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 48,238,850 | 40,716,040 ( 84.41 %) | 0 | 84.41 % |
Company contact information
Puma Biotechnology, Inc.
10880 Wilshire Boulevard Suite 2150
90024-4101, Los Angeles
+
http://www.pumabiotechnology.comSector
1st Jan change | Capi. | |
---|---|---|
+19.41% | 45.51B | |
+38.65% | 39.36B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |